Skip to main content
HIMS
NYSE Life Sciences

Hims & Hers Cuts Full-Year Outlook After Surprise Q3 Loss; Q4 Guidance Misses Consensus

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$22.33
Mkt Cap
$5.352B
52W Low
$13.74
52W High
$42.7
52W Position info
63% above low
Off High info
48% below high
Rel. Volume info
4.4× avg
Market data snapshot near publication time

HIMS sits 63% above its 52-week low of $13.74 on elevated volume (4.4× avg).

Summary

Hims & Hers narrowed full-year revenue guidance to $3.13B-$3.15B from $3.1B-$3.3B and cut its adjusted EBITDA outlook after a surprise Q3 loss of $33M, or 14 cents a share, versus the 6-cent profit analysts expected. The fourth-quarter guide of $875M-$895M lands well below the $953.8M consensus, so the miss extends into the current period rather than being a one-quarter cost blip. Cost of revenue more than doubled and total operating expenses rose 34%, dragging gross margin to 57% from 74% a year earlier even as revenue grew 49% to $890.4M. The company also disclosed the price of its Huberman arrangement: $3.5M in cash over two years for advisory services, up to $1M a year for short-form ads, and up to $5M annually for Scicomm Media podcast advertising over up to three years. The margin compression plus a soft Q4 guide is the part that matters — growth is intact but the cost of getting it is eating the profit line.

At the time of this announcement, HIMS was trading at $22.33 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $13.74 to $42.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $22.32 info
Change: -$1.07 (-5%) info
Market Cap: $5.352B info
HIMS
Nov 09, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.18
Real-time Price: $22.32 info
Change: +$0.1433 (+0.65%) info
Market Cap: $5.352B info
HIMS
Nov 09, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.41
Real-time Price: $22.32 info
Change: -$0.0877 (-0.39%) info
Market Cap: $5.352B info
HIMS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
9
Price at Filing: $22.94
Real-time Price: $22.32 info
Change: -$0.6177 (-3%) info
Market Cap: $5.352B info
HIMS
Nov 09, 2026, 1:20 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $23.30
Real-time Price: $22.32 info
Change: -$0.9761 (-4%) info
Market Cap: $5.352B info